We are live on ! Find out more
MKA

M. Kulyk & Associates Portfolio holdings

AUM $613M
1-Year Est. Return 22.75%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+22.75%
3 Year Est. Return
+63.27%
5 Year Est. Return
+74.76%
10 Year Est. Return
AUM
$330M
AUM Growth
+$30.5M
Cap. Flow
+$11M
Cap. Flow %
3.33%
Top 10 Hldgs %
38.94%
Holding
108
New
7
Increased
64
Reduced
19
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 24.49%
2 Healthcare 10.49%
3 Financials 10.33%
4 Consumer Staples 10.11%
5 Consumer Discretionary 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
101
Costco
COST
$420B
$220K 0.07%
442
MA icon
102
Mastercard
MA
$493B
$214K 0.06%
589
NUSC icon
103
Nuveen ESG Small-Cap ETF
NUSC
$1.33B
$203K 0.06%
+5,741
New +$209K
XLK icon
104
State Street Technology Select Sector SPDR ETF
XLK
$124B
$201K 0.06%
+2,666
New +$183K
TJX icon
105
TJX Companies
TJX
$178B
$200K 0.06%
2,553
-110
-4% -$8.65K
ADP icon
106
Automatic Data Processing
ADP
$108B
-854
Closed -$204K
CI icon
107
Cigna
CI
$74.6B
-753
Closed -$249K
TFC icon
108
Truist Financial
TFC
$64B
-5,298
Closed -$228K

Similar funds

M. Kulyk & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, M. Kulyk & Associates held 108 positions worth $330M, up 10% from $299M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

M. Kulyk & Associates deployed $11M of net new capital in Q1 2023, opening 7 new positions and adding to 64 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 21,886 shares worth $558K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Kellanova, an estimated $111K trimmed.

  • M. Kulyk & Associates's largest Q1 2023 buy was Dimensional US Core Equity 2 ETF: 21,886 shares worth $558K.
  • M. Kulyk & Associates added most to iShares 0-5 Year TIPS Bond ETF in Q1 2023, an estimated $1.12M increase.
  • M. Kulyk & Associates's biggest Q1 2023 reduction was Kellanova, cutting an estimated $111K.
  • M. Kulyk & Associates fully exited Cigna in Q1 2023, selling an estimated $249K.
  • M. Kulyk & Associates's ten largest holdings make up 39% of its $330M portfolio in Q1 2023.
  • M. Kulyk & Associates opened 7 new positions and closed 3 in Q1 2023.
  • M. Kulyk & Associates's portfolio value rose 10% quarter-over-quarter to $330M.

Based on M. Kulyk & Associates's 13F filing for Q1 2023, filed 8 May 2023.